T0	Participants 38 70	growth hormone deficient adults.
T1	Participants 100 119	GH-deficient adults
T2	Participants 221 303	Thirteen GH-deficient adults (4 females, 9 males; mean (SEM) age 26.4 (1.7) years)
T3	Participants 982 997	normal subjects